A new test for diagnosing and predicting Type 1 Diabetes
Official title: Point-of-Care Assay for Type 1 Diabetes Diagnosis and Prognostication
Funded at Electronic Biosciences, INC. · NIH-10721535 · Data updated 2026-11-12
This study is working on a quick and easy test to find early signs of Type 1 Diabetes in kids by checking for certain antibodies, so doctors can help them sooner, even before they feel sick.
Quick facts
| Grant type | Sbir 1 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Electronic Biosciences, INC. NIH-funded |
| Lab location | 1 site (San Diego, United States) |
| Project start | September 1, 2023 |
| Project end | August 31, 2025 |
| Funding year | 2023 |
| Award (this year) | $284,517 |
| NIH project number | 1R43DK136652-01 |
| Project ID | NIH-10721535 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are children aged 0-11 years who are at risk for developing Type 1 Diabetes.
✕Less likely to help
Patients who are already diagnosed with Type 1 Diabetes or those outside the age range of 0-11 years may not benefit from this research.
What this research studies
This research focuses on developing a point-of-care assay to detect autoantibodies associated with Type 1 Diabetes (T1D) in children. By utilizing advanced nanopore technology, the goal is to create a rapid and efficient test that can be performed outside of traditional laboratory settings. This approach aims to identify T1D early, even before symptoms appear, allowing for timely intervention and management. The project builds on previous findings that screening for these autoantibodies can significantly reduce severe complications associated with T1D.
Why it matters
Potential benefit: If successful, this research could lead to earlier diagnosis and better management of Type 1 Diabetes in children, potentially delaying the onset of insulin dependence.
How similar studies have gone: Previous studies have shown that screening for T1D autoantibodies can effectively reduce severe complications, indicating that this approach has a foundation of success.
Where this research is happening
-
Electronic Biosciences, INC.
San Diego, United States Active
Researchers
- Principal investigator: Ervin, Eric — Electronic Biosciences, INC.
- Study coordinator: Ervin, Eric
Related research
Other NIH-funded projects on the same topics.
-
Technological and Educational Approaches to Restore Hypoglycemia Awareness in Type 1 Diabetes
A two-arm study in adults with type 1 diabetes tests whether high-tech glucose control plus education or targeted training can help people regain awareness of low blood sugar.
-
Techniques for restoring awareness of low blood sugar in adults with type 1 diabetes
A randomized trial compares different approaches to help adults with type 1 diabetes recognize when their blood sugar is dipping so they can act quickly.
-
Treating impaired hypoglycemia awareness in type 1 diabetes with targeted education and technology
This study tests two treatment approaches to help adults with type 1 diabetes who often don’t realize their blood sugar is getting too low, using a mix of technology and education in two large groups.
-
Helping people with type 1 diabetes regain awareness of dangerous lows
A UK study tests two different approaches to help adults with type 1 diabetes recognize and respond to low blood sugar by comparing a high-tech insulin system with targeted education.
-
How the pancreas environment affects insulin-producing cells in type 1 diabetes
Researchers are studying how the surrounding tissue of the pancreas and its proteins influence insulin-producing cells in people with type 1 diabetes.
-
Understanding how hypoglycemia awareness changes in adults with type 1 diabetes and how automated insulin delivery and exercise might help restore it
This study will look at adults with type 1 diabetes to see how their awareness of low blood sugar evolves over time and whether automated insulin delivery and high-intensity exercise can help restore that awareness.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.